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ABSTRACT
The G-overhangs of telomeres are thought to
adopt particular conformations, such as T-loops
or G-quadruplexes. It has been suggested that
G-quadruplex structures could be stabilized by spe-
cific ligands in a new approach to cancer treatment
consisting in inhibition of telomerase, an enzyme
involved in telomere maintenance and cell immor-
tality. Although the formation of G-quadruplexes
was demonstrated in vitro many years ago, it has
not been definitively demonstrated in living human
cells. We therefore investigated the chromosomal
binding of a tritiated G-quadruplex ligand,
3H-360A
(2,6-N,N 0-methyl-quinolinio-3-yl)-pyridine dicarbox-
amide [methyl-
3H]. We verified the in vitro selectivity
of
3H-360A for G-quadruplex structures by equilib-
rium dialysis. We then showed by binding experi-
ments with human genomic DNA that
3H-360A has
a very potent selectivity toward G-quadruplex struc-
tures of the telomeric 30-overhang. Finally, we per-
formed autoradiography of metaphase spreads
from cells cultured with
3H-360A. We found that
3H-360A was preferentially bound to chromosome
terminal regions of both human normal (peripheral
blood lymphocytes) and tumor cells (T98G and
CEM1301). In conclusion, our results provide evid-
ence that a specific G-quadruplex ligand interacts
with the terminal ends of human chromosomes.
They support the hypothesis that G-quadruplex
ligands induce and/or stabilize G-quadruplex
structures at telomeres of human cells.
INTRODUCTION
Telomeres, the nucleoprotein structures at the end of euka-
ryotic chromosomes, are essential for chromosome replication
and the prevention of chromosome degradation and fusion.
They are maintained by telomerase, a speciﬁc reverse tran-
scriptase.Thecatalyticsubunitofthisenzyme,hTERT,usesits
RNA subunit (hTR) as a matrix for the addition of GGTTAG
telomere repeats to the 30 ends of chromosomes. Telomerase,
the expression of which is repressed in most somatic human
cells, is reactivated in most tumors (90%) and is thought to
enable cancer cells to proliferate in an unlimited manner, by
maintaining and protecting telomeres (1,2). Telomerase has,
therefore, become a target for the development of new anti-
cancer drugs (3). Various classes of telomerase inhibitors have
been developed in recent years (4,5). G-quadruplex ligands
target the telomeres rather than telomerase itself. Indeed,
structure studies (X-ray crystallography and nuclear magnetic
resonance) of oligonucleotides have indicated that the single-
stranded telomeric-30-overhang could adopt a variety of quad-
ruplex structures based on four Hoogsteen-paired coplanar
guanines (6–8). Various G-quadruplex ligands have been
shown to inhibit telomerase in vitro. Some of these molecules
have also been shown to induce telomere shortening and/or
instability, triggering apoptosis and/or senescence programs
in various cell lines (9–15). However, the precise mechanism
of action of these molecules remains unclear: despite the fact
that the existence of G-quadruplexes was shown in vitro many
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doi:10.1093/nar/gki722years ago, it has not been deﬁnitively demonstrated that
G-quadruplexes exist in vivo, except in ciliates (16) and
Escherichia coli (17). Although it has been proposed that
G-quadruplexes exist in vivo in the promoter of c-myc (18)
and at telomeres (19), their existence in human cells is still a
matter of debate.
In this study, we investigated the targeting in human cells
of 360A (2,6-N,N0-methyl-quinolinio-3-yl-pyridine dicarbox-
amide), a member of a new family of pyridine derivatives
that interact highly selectively in vitro with G-quadruplexes
compared with double-stranded DNA and inhibit telomerase
activity (15,20). This G-quadruplex ligand induces delayed
growth arrest followed by massive apoptosis in various
immortalized cell lines in direct correlation with telomeric
instability (15). We used tritiated-360A to investigate the
behavior of this compound in various cell types. We ﬁrst
checked the in vitro selectivity for G-quadruplex structures
by equilibrium dialysis. Then, we showed by in vitro binding
experiments with human genomic DNA that
3H-360A has a
very potent selectivity toward G-quadruplex structures of the
telomericG-overhang.Finally,weshowedbyautoradiography
of metaphase spreads that tritiated-360A was preferentially
bound to terminal regions of chromosomes of both human
normal cells and immortalized cell lines.
MATERIALS AND METHODS
Chemical compounds
We used a 90.4% pure solution of tritiated-360A (
3H-
360A; 2,6-N,N0-methyl-quinolinio-3-yl)-pyridine dicarbox-
amide [methyl-
3H] di-iodide, formula shown in Figure 1A)
in 50% aqueous ethanol, with a speciﬁc activity of 163 Ci/
mmol. The unlabeled compound, 360A, belongs to a series of
2,6-pyridine-dicarboxamide derivatives displaying strong
afﬁnity and selectivity for G-quadruplex structures and select-
ive telomerase inhibition in in vitro assays (15).
Equilibrium dialysis
We used 400 ml of the dialysate solution containing 130 mCi
3H-360A for each competition dialysis assay. We pipetted
200 mlo fa7 5mM solution of the monomeric unit (nucleotide,
base pair, base triplet or quartet) of each of the nucleic acid
samples (fully described in Table 1) into a separate dialysis
unit (Pierce). All 19 dialysis units were then placed in a beaker
containing the dialysate solution—15 mM sodium cacodylate
(pH 6.5), 10 mM MgCl2 and 185 mM NaCl. This assay has
been described in more detail elsewhere (21). The beaker was
covered with Paraﬁlm, wrapped in aluminum foil, and its
contents were allowed to equilibrate overnight at room tem-
perature (20–22 C), with continuous stirring. DNA samples
were then carefully transferred to microfuge tubes, and the
radioactivity in each chamber was determined with an LKB
Wallac 1211 Rackbeta apparatus (mean of two independent
experiments, each counted twice). The radioactivity signal
is normalized by the signal obtained in a control chamber
that only contains buffer. Binding of the ligand to a nucleic
acid sample leads to an accumulation of the ligand in the
chamber and therefore to an increased normalized radio-
activity signal.
In vitro binding to purified genomic DNA
Aliquots of 2 mg of undigested genomic DNA from A549 cells
were incubated at 50 C overnight with 1 nM (ﬁnal concen-
tration) of
3H-360A in buffer containing 20 mM Tris, pH 8.0,
50 mM NaCl and 1 mM EDTA in a volume of 20 ml in the
presence or absence of competitor oligonucleotides (1 mM),
as indicated. Reactions were stopped by the addition of 6 ml
of loading buffer (20% glycerol, 1 mM EDTA and 0.2% bro-
mophenol blue), and samples were electrophoresed on 0.8%
agarose gels in 1· TBE buffer containing ethidium bromide
(Et-Br). Gels were dried on Whatman ﬁlter paper. Et-Br ﬂuor-
escence and radioactivity were scanned with a Phosphor-
Imager (Thyphoon 9210, Amersham Biosciences). Results
were expressed as the relative binding signal normalized to
the ﬂuorescent signal of Et-Br and represented at least three
independent experiments.
Cells
All cells were cultured at 37 C, in an atmosphere containing
5% CO2. CEM1301 cells (T-cell lymphoblastic leukemia;
DAKO) were cultured at a density of 5 · 10
5/ml in
Figure 1. Structuralselectivityof
3H-360Aasassessedbyequilibriumdialysis.
(A)Chemicalformulaofthecompound.(B)Accumulationoftritiated-360Ain
each dialysis unit. The normalized radioactivity value of ‘1’ corresponds to the
signal obtained in an empty chamber (no DNA; passive diffusion of the radio-
activeligandthroughthedialysismembrane).Bindingoftheligandtoanucleic
acid sample is indicated by a higher than one normalized radioactivity signal.
3H-360A preferentially binds in vitro to quadruplexes, rather than to duplexes
or single strands. The 19 oligo and poly-nucleotide samples used in these
experiments are described in Table 1.
Nucleic Acids Research, 2005, Vol. 33, No. 13 4183RPMI-1640 (Sigma) supplemented with 10% decomplemen-
ted fetal calf serum (FCS) (Invitrogen), 2 mM glutamine
(Sigma) and penicillin–streptomycin (Sigma). Human glioma
T98G cells were cultured in DMEM (Invitrogen) supplemen-
ted with 10%FCS, 2mM glutamine and antibiotics.Peripheral
blood lymphocytes (PBLs) were isolated from blood samples
from normal volunteers (CEN-FAR inﬁrmary) by centrifuga-
tion with Histopaque (Sigma) and cultured at a density of
10
6/ml in M199 medium (Invitrogen) supplemented with 24%
FCS and 1.2% phytohemagglutinin (PHA)-C (Bio-Sepra).
Metaphase preparations and autoradiography
The protocol used was derived from a previously described
method (22). Metaphases were prepared from cells cultured in
their speciﬁc medium supplemented with 0.3 mM
3H-360A at
37 C, in a humidiﬁed atmosphere containing 5% CO2. After
varioustimes,cellswereincubatedwithcolcemid (0.04mg/ml;
Sigma)at37 Cfor40min(CEM1301andT98G)or2h(PBL).
They were then centrifuged (after trypsin treatment for T98G)
at 1500 r.p.m. (GR422, Jouan) for 5 min and the supernatant
was discarded. Warmed hypotonic solution was added to the
cell pellet, which was resuspended by gentle pipetting, and
the resulting suspensionwasincubatedat37 Cfor20min.The
cell suspension was centrifuged at 1400 r.p.m. for 7 min. The
pellet was resuspended and ﬁxed by vortexing twice in etha-
nol:acetic acid (3:1 mixture) and was stored overnight at 4 C.
The suspension was applied on cold wet slides by means
of a dropper for chromosome preparations. The slides were
air-dried overnight. Slides were then incubated in 2· SSC
supplemented with 0.1 mg/ml RNase A (Sigma) for 1 h at
37 C. Slides were washed and dehydrated by successive
ethanol baths and were then air-dried. They were dipped
into Kodak NTB2 nuclear emulsion, developed after exposure
for 2 days and stained with Mayer’s hemalum (Merck). Meta-
phases were captured with an Olympus BX51 microscope. We
counted the number of silver grains suggestive of a telomeric
location for the radioactive compounds (i.e. covering at least
part of the end of a chromatid), and the number of grains
covering other regions of the chromosomes for at least 50
metaphases. The number of silver grains in terminal and
interstitial areas was compared with the total number of
grains in the metaphase areas. We estimated the areas of
the metaphases and the areas in which a grain was considered
to cover a terminal or interstitial region of the chromosome
by means of Metamorph software (Universal Imaging
Table 1. Sequence of the oligo- and poly-nucleotides used in equilibrium dialysis
Number Name Sequence
#1 (T,C) TRIPLEX TT-CTTTCTCTCCTCC-30
50-GAAAGAGAGGAGG-3 0
CC-CTTTCTCTCCTCC-50
#2 (G,A) TRIPLEX TT-GGAGGAGAGAAAG-30
CC-GGAGGAGAGAAAG-50
50-CCTCCTCTCTTTC-3 0
#3 (G,T) TRIPLEX TT-GGTGGTGTGTTTG-30
CC-GGAGGAGAGAAAG-50
50-CCTCCTCTCTTTC-3 0
#4 Poly(dA).2 poly(dT) ...TTTTTTTTTTTTT...-30
...AAAAAAAAAAAAA...-50
...TTTTTTTTTTTTT...-30
#5 24GA (parallel duplex) 50-GAGAGAGAGAGAGAGAGAGAGAGA-30
#6 psD duplex 50-AAAAAAAAAATAATTTTAAATATT-30
50-TTTTTTTTTTATTAAAATTTATAA-30
#7 24CTG 50-CTGCTGCTGCTGCTGCTGCTGCTG-30
#8 Poly(dA–dT) ...ATATATATATATA...-30 (double-stranded DNA polymer)
...TATATATATATAT...-50
#9 Poly(dG–dC) ...GCGCGCGCGCGCG...-30 (double-stranded DNA polymer)
...CGCGCGCGCGCGC...-50
#10 Calf thymus DNA (double-stranded DNA polymer, mixed sequence)
#11 ds 26 50-CAATCGGATCGAATTCGATCCGATTG-30
#12 Poly (dC) 50-...CCCCCCCCCCCCC...-30 (DNA polymer)
#13 22CT 50-CCCTAACCCTAACCCTAACCCT-30
#14 22AG 50-AGGGTTAGGGTTAGGGTTAGGG-30
#15 24G20 50-TTGGGGGGGGGGGGGGGGGGGGTT-30
#16 Poly(dT) (single-stranded) 50-...TTTTTTTTTTTTT...-30 (DNA polymer)
#17 Poly(dA) (single-stranded) 50-...AAAAAAAAAAAAA...-30 (DNA polymer)
#18 Poly(rU) (single-stranded) 50r-...UUUUUUUUUUUU...-30 (RNA polymer)
#19 Poly(rA) (single-stranded) 50r-...AAAAAAAAAAAA...-30 (RNA polymer)
4184 Nucleic Acids Research, 2005, Vol. 33, No. 13Corporation), making it possible to determine silver grain
densities over the various regions. We compared the mean
values obtained statistically by means of t-tests (Statview,
Abacus Concept Inc.).
RESULTS
In vitro selectivity of
3H-360A for G-quadruplex
structures
The selectivity of
3H-360A for G-quadruplex structures was
checked by competitive equilibrium dialysis (Figure 1B). The
sequence and structural selectivity of various DNA binding
agents was previously explored using a thermodynamic-
ally rigorous competition dialysis procedure (23). With this
method, various nucleic acid structures are dialyzed against
a common ligand solution. The amount of ligand accumulated
in the dialysis tube is highest for the tube containing the
structural form with the highest ligand-binding afﬁnity (23),
and the amount of dye bound to a given structure can be
correlated with the afﬁnity of the dye for that sample. We
designed a set of 19 nucleic acid structures (24), ranging
from single strands to G- or C-quadruplexes, and analyzed
the binding of
3H-360A to these structures. The binding pat-
tern of the equilibrium dialysis for
3H-360A was very similar
to the one of the non-radioactive 360A ligand (data not
shown). The tritiated compound accumulated in the two cham-
bers corresponding to DNA quadruplexes (# 14 and 15), but
displayed only minimal binding to regular double-stranded
(# 8–11) or single-stranded (# 16–19) samples. This conﬁrms
that the tritiated ligand bound preferentially to quadruplex
structures (intra- or intermolecular).
However, there was also a signiﬁcant binding to some trip-
lex structures, such as the GT and GA triplexes. The relative
afﬁnity toward quadruplexes was only 1.5- to 2-fold higher
than the afﬁnity for these triplexes. We noticed that these two
triplexes involved guanine-rich strands (50-GAAAGAGAG-
GAGGCCTTGGAGGAGAGAAAG and 50-GAAAGAGA-
GGAGGCCTTGGTGGTGTGTTTG) hybridized to a short
pyrimidine strand (CCTCCTCTCTTTC). Therefore, we anti-
cipated that the quadruplex ligand could have disrupted these
triplexes and bound to the purine-rich strands in a quadruplex
conformation. To test this hypothesis, we performed a similar
dialysis experiment in which binding to triplexes GA and GT
wascomparedwithbindingtotheGAandGTstrands(i.e.inthe
absence of the short pyrimidine oligomer required for triplex
formation). Binding to the GA and GT strands alone was
similar to binding to GA and GT triplexes (data not shown),
strongly suggesting that the apparent strong binding to triplexes
is artefactual, and results from a conversion to a quadruplex in
the presence of the ligand. Finally, we checked that binding to
double-stranded telomeric DNA was minimal, using two dif-
ferent sequences: an intramolecular double-stranded hairpin
with two GGGTTA repeats and an intermolecular 50 d(GG-
GTTA)3GGG/50 d-(CCCTAA)3CCC duplex (data not shown).
3H-360A specifically binds to telomeric G-overhang
from purified genomic DNA
We next studied the binding of
3H-360A to puriﬁed genomic
DNA. Overnight incubation of 1 nM
3H-360A with 2 mg
genomic DNA from A549 cells followed by native agarose
gel electrophoresis allowed to detect the radioactive signal of
the compound at the position of undigested genomic DNA as
a single band (Figure 2B). To determine whether such
ligand has a preference for telomeric sequences, competition
experiments with various oligonucleotides (1 mM) were per-
formed (Figure 2A). As controls, T7 single-stranded oligonuc-
leotide and 21Tel double-stranded telomeric repeats did
not change the binding of the ligand (Figure 2B and C). In
contrast, a competition with the G-quadruplex-forming oligo-
nucleotide 21G abolished the
3H-360A signal (upper band in
Figure 2B and 2C) and most of the
3H-360A radioactivity was
detected at the position of the oligonucleotide (bottom band,
Figure 2D). A related control sequence (21Gmu3) which is
Figure 2. Specific binding of
3H360A to telomeric G-overhang. (A) Sequence
of the oligonucleotide competitor used. (B) Binding of
3H-360A (1 nM) to
purifiedA549genomicDNAafteragarosegelelectrophoresisintheabsenceor
presence of 1 mM oligonucleotide competitors (+21C, +21G, +21Tel, +T7) or
DNA,controlDNAwithout 3H-360A.[3H],radioactivesignalofthegel;Et-Br,
ethidium bromide staining of the gel. (C) Quantification of the
3H-360A bind-
ing to the genomic DNA. The radioactivity signal is normalized relative to the
Et-Br signal, defined as 100% for 1 nM
3H-360A without competitors. The
results corresponded to at least three independent experiments (mean ± SD).
(D) In the presence of 21G (1 mM), most of the
3H360A radioactivity was
detected at the position of the oligonucleotide (indicated by an arrow at the
bottom of the gel).
Nucleic Acids Research, 2005, Vol. 33, No. 13 4185unable to form a G-quadruplex did not compete with the
3H-
360A binding, indicating that
3H-360A has a preference for G-
quadruplex.
Interestingly, the addition of 21C that hybridized to the
telomeric G-overhang and masked the single-stranded part
of telomeric ends decreased the binding of 3H-360A to 65%
of the initial signal (Figure 2B and C). This result suggests
that at least 35% of
3H-360A binding to the genomic DNA
indeed corresponds to a speciﬁc binding to the telomeric
G-overhang.
All together these results conﬁrm the relative speciﬁcity of
3H-360A for G-quadruplexes. They also suggest that roughly
one-third of the 3H-360A binding to the genomic DNA cor-
responded to a speciﬁc binding to the telomeric G-overhang.
The huge molar excess of double-stranded compared with
single-stranded telomeric sequences in the context of a whole
genome could suggest that 3H-360A has a strong preference
for the telomeric G-overhang.
Preferential binding of
3H-360A to terminal regions of
chromosomes in immortalized tumor cells with
short telomeres
We have shown previously that treatment of T98G (a glio-
blastomacelllinewithshorttelomeres<4kb)by360Ainduced
apoptosis in direct correlation with telomeric instability (15)
(datanotshown).Autoradiographs of T98G cells cultured with
0.3 mM
3H-360A for 6–72 h revealed that the tritiated
compound entered the cells within 6 h after the start of treat-
mentandprogressivelyaccumulatedinthenucleioflivingcells
without any permeabilization treatment (Figure 3A and B).
We then investigated the sites to which the compound
bound on genomic DNA by autoradiography of metaphase
spreads of T98G treated with
3H-360A. We observed only
very small numbers of silver grains on autoradiographs from
untreated cultures (Figure 3C and E), enabling us to ignore this
background noise for the interpretation of the data obtained
with the tritiated compound (Figure 3D). Autoradiographs of
T98G cells cultured with
3H-360A showed that grains were
preferentially located on the chromosomes (Figure 3D), indic-
ating that this compound bound to genomic DNA sequences.
Silvergrains were located bothatthe endsofthe chromosomes
(black arrows, referred to here as terminal regions) and on
other chromosomal regions (red arrows, referred to here as
interstitial regions). We compared the putative binding of this
compound to telomeres with that to other regions of chromo-
somes by separately counting the grains on the ends of the
chromosomes and those on interstitial regions from 50 meta-
phases prepared after 24, 48 and 72 h of culture with the
Figure 3. Detectionof
3H-360AbyautoradiographyinT98Gcells.(AandB)AutoradiographsofT98Gculturedwithout(A)orwith(B)
3H-360Afor24h,showing
accumulationoftheradioactivecompoundinnuclei.NucleiwerestainedwithMayer’shemalumsolution.(CandD)AutoradiographsofmetaphasespreadsofT98G
cells cultured without (C) or with (D)
3H-360A for 48 h. Black arrows indicate silver grains on the terminal regions and red arrows indicate silver grains on the
interstitial regions. Bars ¼ 10 mm. (E) Densities of silver grains on the terminal (T) and interstitial (I) regions of chromosomes. Silver grains were counted in
25metaphases/groupforuntreatedcontrolsand50metaphases/groupforcultureswith
3H-360A.Ivalueswerenormalizedtoareasofterminalregionsbydividingthe
totalnumbersofgrainsoninterstitialregionsineachmetaphasebythemeanratioofinterstitialandterminalareasestimatedwithMetamorphsoftware(2.93 ± 0.44at
24h,n ¼ 20;3.52 ± 0.48at48h,n ¼ 20;3.34 ± 0.29at72h,n ¼ 20).Boxesinclude50%ofthevaluescenteredonthemedian(thehorizontallinethroughthebox).
Theverticallinesbeginatthe10thpercentileandendatthe90thpercentile.TvaluesaresignificantlygreaterthanIvalues:*,t-test:P < 0.0001.Similarresultswere
reproduced with another batch of the tritiated compound.
4186 Nucleic Acids Research, 2005, Vol. 33, No. 13tritiated compound (Figure 3E). The areas covered by silver
grains on the interstitial and terminal regions differed in size;
we therefore determined the ratio of these areas with Meta-
morph software and used this ratio to compare the densities of
silver grains on the terminal and interstitial regions for each
metaphase.
The densities of silver grains on the terminal and interstitial
regions increased over time, consistent with nuclear accu-
mulation of the compound. At all incubation times, silver
grain density was signiﬁcantly higher at the ends of the chro-
mosomes than at the interstitial regions (Figure 3E). These
data suggest that the radioactive compound preferentially
bound to the terminal regions of chromosomes, in accordance
with the hypothesis of a preferential binding of
3H-360A to
telomeres.
3H-360A is naturally unstable due to progressive radiolysis,
and the batches should be used within the ﬁrst few weeks after
synthesis in order to be able to analyze the properties of
the intact compound. To perform an additional control of
our autoradiography experiments, we thus used a degraded
batch of
3H-360A that had lost most of its ability to bind
G-quadruplex structures as shown by equilibrium dialysis
(Supplementary Figure 1A). T98G cells were treated for
24 h with this degraded compound and autoradiographies
of metaphases were analyzed using the same method
than that used for the cells treated with the fresh compound.
Results showed no preferential localization of the degraded
radioactive compounds on terminal regions compared
with interstitial regions of chromosomes (Supplementary
Figure 1B) conﬁrming the results obtained with the ‘fresh’
3H-360A.
Preferential binding of
3H-360A to terminal regions of
chromosomes in immortalized tumor cells with very
long telomeres
We repeated these experiments with CEM1301 cells, a
T-lymphoblastic cell line with very long telomeres [mean
telomere restriction fragment (TRF >30 kb, data not shown).
Silver grain densities on terminal regions of chromosomes
of CEM1301 after 24 h of culture with
3H-360A were
signiﬁcantly greater than that calculated for the total meta-
phase area (t-test: P < 0.0001) (data not shown). Moreover,
silver grain densities on terminal regions were also signiﬁc-
antly higher than on the interstitial regions (Figure 4A and C).
In contrast, the degraded sample of 3H-360A did not exhibit
such preferential localization in CEM1301 (Supplementary
Figure 1B), as previously observed in T98G. These
results thus conﬁrmed the preferential accumulation of
3H-360A at the ends of chromosomes. Interestingly, autora-
diographs of CEM1301 cells that have very long telomeres did
not show greater silver grain density at the ends of chromo-
somes than observed for T98G that have short telomeres
(Figure 3E). Hence, the frequency of binding of
3H-360A
to chromosome termini does not appear to depend on telomere
length.
Preferential binding of
3H-360A to terminal regions of
chromosomes in normal lymphocytes
Wethentreated PHA-activated PBLfromahealthy donorwith
3H-360A for 24 h to investigate the binding of the compound
in normal cells. Silver grain density was found again signiﬁc-
antly higher at the ends of chromosomes than on the total
metaphase area (t-test: P < 0.0001) and than on the interstitial
regions (Figure 4B and C, t-test: P < 0.0001), indicating the
preferential binding of the compound to terminal region of
chromosomes from normal as well as cancer cells.
Preferential binding of
3H-360A to terminal regions of
the largest chromosomes in cells lines and PBL
To maximize resolution, we focused on the largest chromo-
somes: chromosome 1 of T98G and CEM1301, which is easy
to identify in these highly rearranged cell lines, and chromo-
somes 1, 2 and 3 from normal PBL. The results (Table 2)
showed that the frequencies of grains were systematically
higher on terminal than on interstitial regions of these chro-
mosomes after various times of treatment in the different cell
types. These data, therefore, conﬁrm preferential binding of
the radioactive compound to chromosome ends. We also
frequently detected grains over the heterochromatic region
of the proximal long arm of chromosome 1, a region rich
Figure 4. Autoradiographs of metaphasespreads from CEM1301(A) and PBL (B) culturedwith
3H-360A. Cells were treated with
3H-360A for 24 h. Black arrows
indicatesilvergrainsontheterminalregionsandredarrowsindicategrainsontheinterstitialregions.(C)Densitiesofsilvergrainsontheterminal(T)andinterstitial
(I)regionsofchromosomesonautoradiographs.Silvergrainswerecountedin50metaphases/group.Ivalueswerenormalizedtoareasofterminalregionsbydividing
thetotalnumbersofgrainsininterstitialregionsineachmetaphasebythemeanratioofinterstitialtoterminalareasestimatedwithMetamorphsoftware(CEM1301:
3.03 ± 0.44, n ¼ 12; PBL: 3.64 ± 0.87, n ¼ 20). Boxes include 50% of the values centered on the median (the horizontal line through the box). The vertical lines
begin at the 10th percentile and end at the 90th percentile. T values are significantly greater than I values: *, t-test: P < 0.0001. Bars ¼ 10 mm.
Nucleic Acids Research, 2005, Vol. 33, No. 13 4187in satellite DNAs, and over the long arm of chromosome 2,
which contains interstitial telomeric sequences (data not
shown).
Distribution of the grains in function of chromosome
lengthconsistentwithapreferentialbindingtotelomeres
We then investigated the hypothesis of a preferential binding
of the compound to chromosome ends by another approach.
We determined the frequency of silver grains per 106 bases
found on some chromosomes (regardless of their location on
those chromosomes) in metaphase spreads of normal PBL.
Theoretically, if
3H-360A binds preferentially to telomeres,
the number of grains/10
6 bases should be greater for smaller
chromosomes than for larger ones. On the contrary, if the
compound does not preferentially bind to telomeres this fre-
quency may either increase along with chromosome length
(for instance if the compound has numerous binding sites
elsewhere in the genome) or may vary independently of chro-
mosome length (for instance if the number of binding sites
depends on chromosomes orif these binding sites are localized
speciﬁcally in terminal regions—but not in telomeres—of
some particular chromosomes). We found that silver grain
frequency (Table 3) was higher for the shortest chromosomes
(19, 20, 21, 22 and Y) than for the longest chromosomes (1, 2
and 3). Therefore, this result conﬁrms the preferential binding
of the compound to terminal versus interstitial chromosome
regions and suggests the existence of similar numbers of bind-
ing sites at all terminal regions of chromosomes. These data
are thus in accordance with the hypothesis of a preferential
binding of the compound to telomeres.
DISCUSSION
Here, we have shown that
3H-360A accumulated in nuclei of
cultured cells and was preferentially bound to terminal regions
of chromosomes of human tumor and normal cells. Such pre-
dominant binding of this speciﬁc G-quadruplex ligand sustains
the hypothesis for the in vivo formation of G-quadruplexes at
telomeres of human cells.
In vitro selectivity of
3H-360A for G-quadruplex
structures
We checked selectivity for G-quadruplexes of
3H-360A by
competitive equilibrium dialysis and by hybridization
experiments with human puriﬁed genomic DNA. The results
obtained conﬁrmed the potent selectivity of 360A toward
G-quadruplexstructurespreviouslydeterminedbyequilibrium
dialysis, FRET experiment or by TRAP-G4 assay (15). We
found that the radioactive compound also interacted with
the triplex samples in the competitive equilibrium dialysis
assay. However, this was likely due to the disruption of
triplexes by the ligand binding the purine-rich strands in a
G-quadruplex conformation as suggested by control experi-
ments without the pyrimidine oligomer that is required
for triplex formation in this assay. Such an allosteric conver-
sion into a different structure in the presence of a DNA
ligand has already been observed for B–Z DNA (25). It
should be noted that a similar behavior has been found for
a number of strong quadruplex ligands (L. Guittat, personal
communication): as the GA and GT triplexes are relatively
easy to unfold (26), conversion to a different structure is
possible.
Table 3. Higher frequencies of silver grains/10
6 bases on shorter than longer
chromosomes, consistent with preferential binding of the G-quadruplex ligand
to telomeres
Chromosomes Chromosome length
(bases · 10
6) (33)
Grains/10
6 bases
1 279 27.6
2 251 27.7
3 221 27.8
19 and 20 72 and 66 33.8
21, 22 and Y 45, 48 and 51 35.9
Thesilvergrainsonterminalandinterstitialregionsofchromosomes1,2and3
wereseparatelynumberedin76metaphasesofnormalPBLtreatedfor24hwith
3H-360A. The frequencies of silver grains/10
6 bases were then deduced from
the respective length of each chromosome. The same method was applied to
the shorter chromosomes, except that chromosomes that were not easily
distinguishable from each other by the technique used were analyzed together
in two separate groups (chromosomes 19 and 20) and (chromosomes 21, 22
and Y).
Table2.Comparisonbetweenfrequenciesofsilvergrainsontheterminal(FT)andinterstitial(FI)regionsofchromosomes1,2and3inmetaphasespreadsofT98G
cells, CEM1301 cells, and normal PBL treated with
3H-360A
Cell Time (h) Chromosomes Mean ratio of
interstitial/terminal
areas ± SD
Number of
metaphases
examined
Frequency of
grains on terminal
regions (FT)
Frequency of grains
on interstitial
regions (FI)
FT/FI
CEM1301 24 1 3.37 ± 0.65 50 0.120 0.056 2.14
T98G 24 1 4.10 ± 0.33 38 0.132 0.037 3.57
48 1 4.10 ± 0.33 42 0.155 0.070 2.21
72 1 4.10 ± 0.33 50 0.215 0.076 2.83
PBL1 24 1 5.98 ± 1.64 76 0.236 0.089 2.65
24 2 5.21 ± 1.63 76 0.196 0.096 2.04
24 3 4.26 ± 1.16 76 0.196 0.098 2.00
PBL2 72 1 5.11 ± 0.86 50 0.280 0.102 2.75
72 2 4.43 ± 0.83 50 0.160 0.120 1.33
72 3 3.35 ± 0.70 50 0.110 0.090 1.22
PBLwerecollectedfromtwodifferentdonors(PBL1andPBL2).Frequenciesaregivenfor1chromosome/metaphase.FIwascalculatedbydividingthefrequencyof
silvergrainsoninterstitialsequencesbythemeanratioofinterstitialareasversusterminalareas.Interstitialandterminalareasofchromosomeswereestimatedusing
Metamorph software (CEM1301: n ¼ 37, T98G: n ¼ 35, PBL: n ¼ 50 for each donor).
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By comparing the densities of silver grains in autoradiograph-
ies of metaphase spreads, we found that
3H-360A preferen-
tially bound to terminal regions of chromosomes of two tumor
cell lines (T98G and CEM1301) and also of normal PBL. The
speciﬁcity of this binding was conﬁrmed: (i) by the lack of
such preferential localization of degraded compounds lacking
afﬁnity for G-quadruplex structures and (ii) by focusing on the
localization of
3H-360A on the largest chromosomes. Finally,
the comparison of silver grain frequencies per chromosome
sustained the hypothesis of a preferential localization of the
compounds at terminal regions of all chromosomes. Our res-
ults do not rule out the possibility of speciﬁc binding sites
located in interstitial sequences, such as in promoters of some
speciﬁc genes (18). However, they indicate that a signiﬁcant
fraction of the binding sites of the compound is located at the
terminal regions of chromosomes.
Binding sites of
3H-360A at chromosomes ends
We showed by the comparisonof CEM1301 and T98G thatthe
binding of the compound to the terminal regions of chromo-
somes was not a simple function of telomere length as deﬁned
by mean TRF length determination. This is in agreement with
in vitro data showing ﬁrst that competition with a double-
stranded telomeric oligonucleotide does not affect the
3H-360A binding to genomic DNA and, second, that 360A
very weakly binds to double-stranded telomeric repeats as
compared with quadruplexes in a competitive dialysis experi-
ment with a different set of sequences (data not shown).
Although the formation of G-quadruplex could occur all
along the double-stranded telomeric DNA in particular cir-
cumstances (27,28), it is thought more likely to occur at the
telomeric overhang because it does not necessitate the separa-
tion of the two strands of DNA, which could be unfavorable
under physiological conditions (29). Such a preference for the
telomeric G-overhang has been already reported for telomes-
tatin, another G-quadruplex ligand (30–32). Our data showing
that binding of
3H-360A to terminal regions of chromosomes
is independent of the double-stranded telomere length ﬁt well
with the hypothesis of a predominant binding to telomeric
overhangs. Consistent with this hypothesis, in vitro hybridiza-
tion and competition experiments on puriﬁed genomic DNA
indicated that
3H-360A has a preference for G-quadruplex
structures formed by the telomeric overhang. However, we
also showed in this assay that the ligand could bind to other
sequences than the telomeric overhang. Such sites along telo-
meres and also G-rich subtelomeric sequences could thus
contribute at least in part for the predominant localization
of the compound at terminal regions of chromosomes found
by autoradiography. They could possiblyresult from processes
that require strands separation, such as DNA replication, that
could allow the binding of the compound to G-quadruplex-
forming elements on the single stranded DNA.
Binding of the G-quadruplex ligands to chromosome
ends and cellular effects
We have shown elsewhere that the induction of apoptosis
in immortalized cell lines by G-quadruplex ligands from
our pyridine derivative series is related to multiple cell cycle
alterations, including checkpoint activation, increase in meta-
phase duration and cytokenesis defects (15). All these effects
are correlated with an induction of telomeric instability as
shown by telomere-end fusion and anaphase bridge formation
(15), indicating that these compounds act at telomeres. The
data in the present study support the notion that the telomeric
instability induced by G-quadruplexes interacting pyridine
derivatives in immortalized cell lines is a direct consequence
of the binding of the compounds to chromosome ends.
In conclusion, our results provide new evidences that
a speciﬁc G-quadruplex ligand interacts with the terminal
regions of chromosomes in human living cells. They support
the hypothesis that G-quadruplex ligands induce and/or sta-
bilize G-quadruplex structures at telomeres of human cells,
at least in part at telomere overhang. We also found that this
could occur in normal cells and immortalized cell lines.
Interestingly, the non-radioactive form of our compound,
360A, has limited effects on proliferation of normal cells
(C. Granotier et al., manuscript in preparation) as previously
reported for telomestatin (12). 360A only slows the growth
of normal PBL—without induction of apoptosis—and at
higher concentrations than that required to induce apoptosis
in tumor cell lines. We thus hypothesize that the binding of
the compound to terminal region of chromosomes triggers
different intracellular pathways between normal and tumor
cells. All together, our results reinforce the hypothesis that
G-quadruplexes may be formed at the ends of human chro-
mosomes.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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